Main Article Content
Abstract
Juvenile myoclonic epilepsy is one type of epileptic syndrome typically manifesting in adolescence, presented with myoclonic seizure in all affected individuals. We reported a 12-year-old girl with her recurrent episodes of myoclonic seizure. Physical examination, vital signs, and general status were normal. An increased muscle tone was found in neurological examination. An electroencephalogram was performed and showed polyspike-and-wave patterns consistent with JME. An abnormality was found in brain MRI. The patient was managed with antiseizure medication. Subsequently, the patient showed an improvement. This case report highlights the importance of early diagnosis, proper management, and prognosis of children with juvenile myoclonic epilepsy.
Keywords
Article Details
References
- Møller, R. S., & Iona, J. G. Genetic aspects of juvenile myoclonic epilepsy. Epilepsy & Behavior. 2013;
- (Suppl. 1), S1-S7.
- doi:10.1016/j.yebeh.2013.05.012.
- Alfradique, I., Vasconcelos, M. M. Juvenile Myoclonic Epilepsy. Arq Neuropsiquiatr. 2007; 65(4-B):1266-1271.
- Mehndiraa, M. M., Aggarwal, P. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India. Sei- zure. 2002; 11:431-436.
- Verroi, A., Manco, R., Marco, G., Chiarelli, F., Franzoni, E. The treatment of juvenile myoclonic epilepsy. Expert Rev Neurother. 2006;6:847-854.
- Glauser, T., Ben-Menachem, E., Bourgeois, B., et al. ILAE Treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47:1094-1120.
- Arzimanoglou, A., Guerrini, R., Aicardi, J. Epilepsies with predominantly myoclonic seizures. In Arzimanoglou A, Guerrini R, Aicardi J (Eds). Aicardi’s epilepsy in children. Philadelphia: Lippincott Williams & Wilkins, 2004:58-80.
- Bergey, G. K. Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs. Epilepsia 2005;46(Suppl 9):S161-S1683.
- Shah, S., Sher, K., Sattar, R. A. Clinical and EEG characteristics of juvenile myoclonic epilepsy . Pak J Med Sci. 2014, 30:12-15. 10.12669/pjms.301.4465.
- Santos, B. P. D., Marinho, C. R. M., Marques, T. E. B. S, et al. Genetic susceptibility in juvenile myoclonic epilepsy: systematic review of genetic association studies. PLoS One. 2017; 12:e0179629. 10.1371/journal.pone.0179629.
References
Møller, R. S., & Iona, J. G. Genetic aspects of juvenile myoclonic epilepsy. Epilepsy & Behavior. 2013;
(Suppl. 1), S1-S7.
doi:10.1016/j.yebeh.2013.05.012.
Alfradique, I., Vasconcelos, M. M. Juvenile Myoclonic Epilepsy. Arq Neuropsiquiatr. 2007; 65(4-B):1266-1271.
Mehndiraa, M. M., Aggarwal, P. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India. Sei- zure. 2002; 11:431-436.
Verroi, A., Manco, R., Marco, G., Chiarelli, F., Franzoni, E. The treatment of juvenile myoclonic epilepsy. Expert Rev Neurother. 2006;6:847-854.
Glauser, T., Ben-Menachem, E., Bourgeois, B., et al. ILAE Treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47:1094-1120.
Arzimanoglou, A., Guerrini, R., Aicardi, J. Epilepsies with predominantly myoclonic seizures. In Arzimanoglou A, Guerrini R, Aicardi J (Eds). Aicardi’s epilepsy in children. Philadelphia: Lippincott Williams & Wilkins, 2004:58-80.
Bergey, G. K. Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs. Epilepsia 2005;46(Suppl 9):S161-S1683.
Shah, S., Sher, K., Sattar, R. A. Clinical and EEG characteristics of juvenile myoclonic epilepsy . Pak J Med Sci. 2014, 30:12-15. 10.12669/pjms.301.4465.
Santos, B. P. D., Marinho, C. R. M., Marques, T. E. B. S, et al. Genetic susceptibility in juvenile myoclonic epilepsy: systematic review of genetic association studies. PLoS One. 2017; 12:e0179629. 10.1371/journal.pone.0179629.